Objective: Adiponectin and leptin play critical roles in the development of Metabolic Syndrome (MetS). is study was designed to assess the feasibility of using circulating levels of adiponectin and leptin for the early diagnosis of MetS.
Adipocytes-derived hormones, also known as adipokines, serve as mediators linking adipocyte dysfunction to Metabolic Syndrome (MetS). Two of the most studied adipokines, adiponectin and leptin, have been shown to be critical in the development of MetS [1, 2] . Adiponectin, the most abundant adipokine in circulation, has direct e ects on insulin sensitivity, glucose metabolism and central fat distribution. Adiponectin exerts its e ect on glucose metabolism by regulating mRNA expression of the hepatic gluconeugenic enzymes [3, 4] . Lower levels of adiponectin are associated with insulin resistance and endothelial cell dysfunction, and are also observed in proin ammatory and prothrombotic states. Leptin, on the other, hand plays a critical role in regulating food intake [5] , maintaining energy expenditure [6] and regulating immune function [7] . Increased leptin levels in plasma suggest the development of leptin resistance; an early manifestation of MetS [8] .
Because of their critical roles in the development of MetS, adiponectin, leptin and the adiponectin/lectin ratio have been suggested to be useful serum markers for diagnosis of MetS [9] [10] [11] . Adiponectin and leptin have been evaluated independently for their ability to diagnose MetS in several ethnic and racial backgrounds, such as Chinese [11, 12] , Japanese, Caucasian [12] and Korean [9] , using a case-control design. Despite the higher prevalence of MetS in Mexican-Americans [13] , no study has assessed the relative importance of adiponectin, leptin and adiponectin/leptin ratio in MetS in this population. In the present cross-sectional study, the performance of circulating levels of adiponectin and leptin and adiponectin/leptin ratio to diagnose MetS in a Mexican-American population residing on the Texas-Mexico border. is population presents with severe health issues, including obesity, type 2 diabetes and cardiovascular disease [14, 15] . Given these health issues, any e orts to provide early diagnoses of MetS would allow for early treatment and would reduce long-term complications.
Methods

Study population
e study was conducted on 367 randomly selected individuals from the Cameron County Hispanic Cohort (CCHC) [14] . Written, informed consent was obtained from participants at the time of enrollment and the study was approved by the UTHealth Science Center, Institutional Review Board (IRB) and the Committee for the Protection of Human Subjects (CPHS). Characteristics of these participants are described in Table 1 . e plasma specimen were obtained and stored as described previously [14] .
Measurement of adiponectin and leptin
e levels of total adiponectin and total leptin were measured in frozen plasma specimen using a multiplex ELISA (Milliplex Map, Millipore Corp., Temecula, CA) and read in a Luminex 200 system (Luminex Corp., Austin, TX). e two adipokines were run in separate panels because of the dilution factor. e panels were evaluated for the coe cient of variation, linearity of dilution and spike/recovery. e inter-assay variability for adiponectin was 5.6% and intra-assay variation was 15%. e accuracy (spike recovery) was measured by using known standards where data represent the mean percent recovery of the di erent levels of spiked standards in serum matrices in several independent experiments. Values of adiponectin were reported as micrograms/ml (µg/ml) and leptin as picograms/ml (pg/ ml). Final.pdf ). Many individuals with suspected MetS in our CCHC did not meet the de nition criteria for MetS proposed in these guidelines. We therefore used the unsupervised learning algorithm, the K-means clustering method, for a computeraided diagnosis (CAD) of MetS. e K-means classi cation was based on ve groups of variables: (i) body mass index (BMI) and waste circumference; (ii) fasting plasma glucose (FPG), fasting plasma insulin (FPI) and homeostasis model assessment estimated insulin resistance (HOMA-IR) index; (iii) fasting serum triglycerides and total cholesterol; (iv) blood pressure; and, (v) serum alanine aminotransferease (ALT) and aspartate amino transferease (AST) levels. e reference ranges of BMI, waist circumference, serum triglycerides and total cholesterol and blood pressure were based on the recommendation of the American Heart Association (www.americanheart.org).
K-means classi cation for MetS
e reference range of FPG was based on the 2010 Clinical Practice Recommendations of the American Diabetes Association (ADA) [16] . e reference for HOMA-IR was based on previous research using the CCHC that included 1854 Mexican-Americans (manuscript submitted to Diabetes Care).
e references ranges are listed in Supplementary Table 1 .
Receiver operator characteristic (ROC) analysis
To assess the diagnostic value of adiponectin/leptin for diagnosis of MetS, receiver operator characteristics (ROC) analyses were performed based on the sensitivity and speci city values of a series of cuto s of -log10 (adiponectin/leptin). In the investigation of a new diagnostic marker of disease, ROC analysis provides a direct assessment of the sensitivity (true positive rate) and the speci city (true negative rate) of using this marker for diagnosis. e performances of a series of cuto s were assessed using the maximum Matthews correlation coecient (MCC).
Statistical method
K-means classi cation, linear regression and independent sample t-tests used in this study were performed using the SPSS Statistics version 19 (IBM Corp., Chicago, IL). Table 3 ). Consequently, the population was strati ed by gender to investigate the association between adiponectin/leptin and MetS. e observation that adiponectin/leptin is a better marker than either adipokine or leptin alone was further supported by our test of their correlations with MetS diagnosis: a er adjusting for age and gender, the correlation between leptin levels and MetS diagnosis was r=0.294, and the correlation between adiponectin levels and MetS diagnosis was r=0.360, whereas the correlation between adiponectin/leptin and MetS diagnosis was r=0.500. Secondly, the performance of the K-means clustering of MetS was assessed. Major components of MetS between the two K-means clusters were compared; i.e.,the MetS cluster vs. the healthy cluster. Results indicated signi cant di erences in components of MetS between those two clusters as assessed by K-means (Supplementary A receiver operator characteristic (ROC) analysis was performed to assess the performance of adiponectin/leptin as a diagnostic marker for MetS (Fig 1, Table 2 ). e ROC analysis indicated that, in males, -log 10 (adiponectin/leptin) at the cuto of 3.0 had the maximum MCC. With this cuto , -log 10 (adiponectin/leptin) has a sensitivity of 71.9% and a speci city of 90.2% for the diagnosis of MetS. A total of 39.8% males in our study population had -log 10 (adiponectin/leptin) ≥ 3.0, a cut-o value that is suggestive of MetS. For females, -log 10 (adiponectin/leptin) at the cuto of 3.2 had the maximum MCC, where -log 10 (adiponectin/leptin) can be used to assist the diagnosis of MetS with a sensitivity of 78.9% and a speci city of 69.8%. A total of 54.2% of females in our study had -log10(adiponectin/leptin) of ≥ 3.2, suggesting MetS.
Results
ese robust results of the ROC analysis with high sensitivity and speci city highlighted the adiponectin/leptin as a valuable biomarker for diagnosis of MetS. In addition, our analysis demonstrated the role of adiponectin/leptin for the diagnosis of MetS, independent of BMI. Taking BMI into consideration, the correlation between adiponectin/leptin and the diagnosis of the MetS has r=0.301, p=4.12x10 -9 .
Conclusion
Because of their critical roles in MetS, adiponectin, leptin, especially their ratio, have been proposed as potential serum markers for MetS [9] [10] [11] [12] . In this study, both adiponectin and leptin were found to be independently associated with age, while the ratio of two remained una ected by age. Aging is an important biological factor for MetS and has been shown to be associated with a pro-in ammatory state and subsequent alterations in levels of metabolic markers, including adiponectin and leptin. e observation that age was independently associated with leptin and adiponectin, suggests that age is a confounder, when either marker is used alone. As the ratio of the two markers is independent of age, it would serve as a better diagnostic marker of MetS than the two adipokines separately e remarkable sensitivity and speci city observed in our study indicates that adiponectin/leptin is a valuable marker for MetS -a pathological condition for which there is currently no sensitive diagnostic test. Adiponectin/leptin and the K-means classi cation of MetS, which are two independent diagnostic systems, showed signi cantly high association with each other.
is highly speci c association highlights the central role of adiponectin/leptin in predicting MetS. e strong association between adiponectin/leptin and the Computer Aided Diagnosis (CAD) of MetS also suggests that the IDF and ATPIII guidelines lack the sensitivity required to diagnose MetS.
In order to prevent the downstream e ects of MetS, it is essential to identify the disease in its early stages and to initiate early treatment. Supplementary to previously conducted casecontrol studies [11, 17, 18] , this cross-sectional study provides an empirical assessment of adiponectin/leptin as a potentially valuable biomarker for diagnosing MetS. 
